T. Rowe Price Associates
MTEM

T. Rowe Price Associates’s Molecular Templates, Inc. MTEM Stock Holding History

T. Rowe Price Associates’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-667
Closed -$4K – 2985
2023
Q1 		$4K Hold
667
– – ﹤0.01% 2908
2022
Q4 		$3K Hold
667
– – ﹤0.01% 2923
2022
Q3 		$8K Sell
667
-1,238
-65% -$15.6K ﹤0.01% 2935
2022
Q2 		$26K Sell
1,905
-239
-11% -$5.59K ﹤0.01% 2918
2022
Q1 		$111K Buy
2,144
+80
+4% +$3.53K ﹤0.01% 2831
2021
Q4 		$121K Sell
2,064
-80,666
-98% -$6.04M ﹤0.01% 2850
2021
Q3 		$8.33M Sell
82,730
-187
-0.2% -$19.3K ﹤0.01% 1442
2021
Q2 		$9.73M Buy
82,917
+26,516
+47% +$3.47M ﹤0.01% 1421
2021
Q1 		$10.7M Buy
56,401
+54,375
+2,684% +$9.53M ﹤0.01% 1384
2020
Q4 		$285K Buy
2,026
+5
+0.2% +$739 ﹤0.01% 2438
2020
Q3 		$331K Hold
2,021
– – ﹤0.01% 2255
2020
Q2 		$418K Buy
+2,021
New +$470K ﹤0.01% 2122
2014
Q1 		– Sell
-1,160
Closed -$894K – 2522
2013
Q4 		$894K Sell
1,160
-5,210
-82% -$3.93M ﹤0.01% 1704
2013
Q3 		$4.89M Sell
6,370
-30
-0.5% -$24.6K ﹤0.01% 1431
2013
Q2 		$5.55M Buy
+6,400
New +$5.41M ﹤0.01% 1389

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

T. Rowe Price Associates's MTEM Position: Q2 2023 in Review

T. Rowe Price Associates sold out of Molecular Templates, Inc. (MTEM) in Q2 2023, closing a stake of 667 shares — an estimated $4K sold.

T. Rowe Price Associates first reported a position in MTEM in Q2 2013 and held it in 15 quarters. The position peaked at $10.7M in Q1 2021. 41 funds tracked by Wall St. Rank hold MTEM as of Q2 2023.

  • T. Rowe Price Associates reported no remaining Molecular Templates, Inc. position as of Q2 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 667 Molecular Templates, Inc. shares in Q2 2023, an estimated $4K.
  • T. Rowe Price Associates first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 15 quarters.
  • T. Rowe Price Associates's Molecular Templates, Inc. position peaked at $10.7M in Q1 2021.
  • 41 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2023.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.